Abstract:Increasing evidence suggests that systemic inflammation triggers a neuroinflammatory response that involves sustained microglia activation. This response has deleterious consequences on memory and learning capability in experimental animal models and in patients. However, the mechanisms connecting systemic inflammation and microglia activation remain poorly understood. Here, we identify the autotaxin (ATX)/lysophosphatidic acid (LPA)/LPA-receptor axis as a potential pharmacological target to modulate the LPS-mediated neuroinflammatory response in vitro (the murine BV-2 microglia cell line) and in vivo (C57BL/6J mice receiving a single i.p. LPS injection). In LPS-stimulated (20 ng/mL) BV-2 cells, we observed increased phosphorylation of transcription factors (STAT1, p65, and c-Jun) that are known to induce a proinflammatory microglia phenotype. LPS upregulated ATX, TLR4, and COX2 expression, amplified NO production, increased neurotoxicity of microglia conditioned medium, and augmented cyto-/chemokine concentrations in the cellular supernatants. PF8380 (a type I ATX inhibitor, used at 10 and 1 μM) and AS2717638 (an LPA5 antagonist, used at 1 and 0.1 μM) attenuated these proinflammatory responses, at non-toxic concentrations, in BV-2 cells. In vivo, we demonstrate accumulation of PF8380 in the mouse brain and an accompanying decrease in LPA concentrations. In vivo, co-injection of LPS (5 mg/kg body weight) and PF8380 (30 mg/kg body weight), or LPS/AS2717638 (10 mg/kg body weight), significantly attenuated LPS-induced iNOS, TNFα, IL-1β, IL-6, and CXCL2 mRNA expression in the mouse brain. On the protein level, PF8380 and AS2717638 significantly reduced TLR4, Iba1, GFAP and COX2 expression, as compared to LPS-only injected animals. In terms of the communication between systemic inflammation and neuroinflammation, both inhibitors significantly attenuated LPS-mediated systemic TNFα and IL-6 synthesis, while IL-1β was only reduced by PF8380. Inhibition of ATX and LPA5 may thus provide an opportunity to protect the brain from the toxic effects that are provoked by systemic endotoxemia.

Panobinostat, a Histone Deacetylase Inhibitor, Reduces LPS-Induced Expression of Inducible Nitric Oxide Synthase in Rat Immortalized Microglia HAPI Cells

Pannexin1 Channel Inhibitor (10panx) Protects Against Transient Focal Cerebral Ischemic Injury by Inhibiting RIP3 Expression and Inflammatory Response in Rats.

Activation of the RON Receptor Tyrosine Kinase by Macrophage-stimulating Protein Inhibits Inducible Cyclooxygenase-2 Expression in Murine Macrophages

[Effect of 1400W, an Inhibitor of Inducible Nitric Oxide Synthetase, on Blocking the Toxicity of Lipopolysaccharide-Induced Activated Microglia to Preoligodendrocytes].

Inhibition Of Lipopolysaccharide-Induced Expression Of Inducible Nitric Oxide Synthase By Phenolic (3e)-4-(2-Hydroxyphenyl)But-3-En-2-One In Raw 264.7 Macrophages

Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IκB signaling pathways

Post-transcriptional regulation of inducible nitric oxide synthase (iNOS) by Protein Interacting with Never in Mitosis Gene A-1 (PIN1) in murine aortic endothelial cells

Peroxisome Proliferator-Activated Receptor-Γ Agonists Suppress Inos Expression Induced by LPS in Rat Primary Schwann Cells

Pazopanib alleviates neuroinflammation and protects dopaminergic neurons in LPS-stimulated mouse model by inhibiting MEK4-JNK-AP-1 pathway

PPARγ Agonist Pioglitazone Inhibits Microglia Inflammation by Blocking P38 Mitogen-Activated Protein Kinase Signaling Pathways

Inhibition of Nitric Oxide Synthase Expression by Ppm-18, A Novel Anti-Inflammatory Agent, in Vitro and in Vivo

Regulation of Inducible Nitric Oxide Synthase Expression by P300 and P50 Acetylation.

MOLECULAR MECHANISMS OF PROPOFOL-INVOLVED SUPPRESSION OF NO BIOSYNTHESIS AND INDUCIBLE iNOS GENE EXPRESSION IN LPS-STIMULATED MACROPHAGE-LIKE RAW 264.7 CELLS

Panobinostat Attenuates Experimental Autoimmune Encephalomyelitis in Mice via Suppressing Oxidative Stress-Related Neuroinflammation and Mitochondrial Dysfunction

HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride

Inducible Nitric-oxide Synthase Expression is Regulated by Mitogen-activated Protein Kinase Phosphatase-1

Nardosinanone N Suppresses LPS-induced Macrophage Activation by Modulating the Nrf2 Pathway and Mpges-1.

Inhibition of Interleukin-12 P40 Transcription and NF-κB Activation by Nitric Oxide in Murine Macrophages and Dendritic Cells*

Inhibition of Autotaxin and Lysophosphatidic Acid Receptor 5 Attenuates Neuroinflammation in LPS-Activated BV-2 Microglia and a Mouse Endotoxemia Model

Protein Never in Mitosis Gene A Interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells.

Stat1 Acetylation Inhibits Inducible Nitric Oxide Synthase Expression in Interferon-Gamma-Treated Raw264.7 Murine Macrophages